Literature DB >> 17403994

Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals.

Maria Virginia Villegas1, Juan Nicolas Kattan, Adriana Correa, Karen Lolans, Ana Maria Guzman, Neil Woodford, David Livermore, John P Quinn.   

Abstract

During 2005, 66 carbapenem-resistant isolates of Acinetobacter baumannii were collected from seven tertiary-care hospitals participating in a nationwide surveillance network in Colombia. The isolates were multidrug resistant and produced the carbapenemases OXA-23 and OXA-51. Forty-five belonged to four clones while 21 were unique pulsotypes. One clone was present in two hospitals within one city, while another had spread between two hospitals in different cities. Blood, secretions, and abdominal fluids were the most frequent sites of isolation. This is the first description of widespread dissemination of OXA-23 in South America.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403994      PMCID: PMC1891364          DOI: 10.1128/AAC.00226-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.

Authors:  Jane F Turton; M Elaina Ward; Neil Woodford; Mary E Kaufmann; Rachel Pike; David M Livermore; Tyrone L Pitt
Journal:  FEMS Microbiol Lett       Date:  2006-05       Impact factor: 2.742

Review 2.  The threat from the pink corner.

Authors:  David M Livermore
Journal:  Ann Med       Date:  2003       Impact factor: 4.709

3.  First report of OXA-23 carbapenemase in clinical isolates of Acinetobacter species in the Irish Republic.

Authors:  T W Boo; F Walsh; B Crowley
Journal:  J Antimicrob Chemother       Date:  2006-08-17       Impact factor: 5.790

4.  [Antimicrobial resistance in gram negative bacteria isolated from intensive care units of Colombian hospitals, WHONET 2003, 2004 and 2005].

Authors:  María Consuelo Miranda; Federico Pérez; Tania Zuluaga; María del Rosario Olivera; Adriana Correa; Sandra Lorena Reyes; Maria Virginia Villegas
Journal:  Biomedica       Date:  2006-09       Impact factor: 0.935

5.  Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Pierre-Edouard Fournier; Jean-Michel Claverie; Didier Raoult; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

6.  Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia.

Authors:  Thierry Naas; Marc Levy; Claire Hirschauer; Hélène Marchandin; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 7.  Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.

Authors:  L Poirel; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

Review 8.  OXA (beta)-lactamases in Acinetobacter: the story so far.

Authors:  Susan Brown; Sebastian Amyes
Journal:  J Antimicrob Chemother       Date:  2005-12-06       Impact factor: 5.790

9.  Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England.

Authors:  Juliana M Coelho; Jane F Turton; Mary E Kaufmann; Judith Glover; Neil Woodford; Marina Warner; Marie-France Palepou; Rachel Pike; Tyrone L Pitt; Bharat C Patel; David M Livermore
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

10.  ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii.

Authors:  R Paton; R S Miles; J Hood; S G Amyes; R S Miles; S G Amyes
Journal:  Int J Antimicrob Agents       Date:  1993-02       Impact factor: 5.283

View more
  21 in total

1.  First identification of OXA-72 carbapenemase from Acinetobacter pittii in Colombia.

Authors:  Maria Camila Montealegre; Juan José Maya; Adriana Correa; Paula Espinal; Maria F Mojica; Sory J Ruiz; Fernando Rosso; Jordi Vila; John P Quinn; Maria Virginia Villegas
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

2.  In memoriam: John P. Quinn, MD.

Authors:  Federico Perez; Cesar A Arias; Karen Bush; George L Drusano; Karen Lolans; L Silvia Munoz-Price; David P Nicolau; Anne Marie Queenan; Louis B Rice; John Segreti; David M Shlaes; Robert A Weinstein; Robert A Bonomo
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

3.  Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil.

Authors:  A F Martins; R Kuchenbecker; T Sukiennik; R Boff; K C Reiter; L Lutz; A B M P Machado; A L Barth
Journal:  Infection       Date:  2009-09-18       Impact factor: 3.553

Review 4.  Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients.

Authors:  Elisabeth Paramythiotou; Christina Routsi
Journal:  World J Crit Care Med       Date:  2016-05-04

5.  In vitro pharmacodynamics of various antibiotics in combination against extensively drug-resistant Klebsiella pneumoniae.

Authors:  Tze-Peng Lim; Yiying Cai; Yanjun Hong; Eric Chun Yong Chan; Sasikala Suranthran; Jocelyn Qi-Min Teo; Winnie Huiling Lee; Thean-Yen Tan; Li-Yang Hsu; Tse-Hsien Koh; Thuan-Tong Tan; Andrea Lay-Hoon Kwa
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

6.  Dissemination of multidrug resistant Acinetobacter baumannii in various hospitals of Antananarivo Madagascar.

Authors:  Tahiry S Andriamanantena; Elisoa Ratsima; Hanitra C Rakotonirina; Frédérique Randrianirina; Lovasoa Ramparany; Jean-François Carod; Vincent Richard; Antoine Talarmin
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-06-30       Impact factor: 3.944

Review 7.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

8.  Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp.

Authors:  Laurent Poirel; Samy Figueiredo; Vincent Cattoir; Alessandra Carattoli; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-01-14       Impact factor: 5.191

Review 9.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 10.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.